The Technical AnalystExchange: EURONEXT Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Laboratorio Reig Jofre, Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.74% €2.73
America/New_York / 17 mai 2024 @ 11:22
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 215.12 mill |
| EPS: | 0.120 |
| P/E: | 22.75 |
| Earnings Date: | Jul 29, 2024 |
| SharesOutstanding: | 78.80 mill |
| Avg Daily Volume: | 0.0147 mill |
| RATING 2024-05-17 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | ||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.33x |
| Company: PE 22.75 | sector: PE 17.08 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.96x |
| Company: PE 22.75 | industry: PE 23.71 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€-2.28 (-183.38%) €-5.01 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
€ 2.66 - 2.80 ( +/- 2.56%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €2.73 (0.74% ) |
| Volume | 0.0101 mill |
| Avg. Vol. | 0.0147 mill |
| % of Avg. Vol | 68.58 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RJF.MC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RJF.MC
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.